tiprankstipranks
Advertisement
Advertisement

NCNA Stock Latest News

NuCana Files Q2 2026 Results and Updates U.S. Registration Statements
Company AnnouncementsNuCana Files Q2 2026 Results and Updates U.S. Registration Statements
6d ago
6K
NCNA
NuCana Shareholders Approve All Resolutions at June 2026 AGM
PremiumCompany Announcements
NuCana Shareholders Approve All Resolutions at June 2026 AGM
2M ago
6K
NCNA
NuCana appoints Ian Webster as CFO
PremiumThe Fly
NuCana appoints Ian Webster as CFO
3M ago
NCNA
NuCana Confirms Ian Webster as CFO to Steer Oncology Pipeline Through Key 2026 Milestones
PremiumCompany Announcements
NuCana Confirms Ian Webster as CFO to Steer Oncology Pipeline Through Key 2026 Milestones
3M ago
6K
NCNA
NuCana Posts Wider Q1 2026 Loss as Cash Balance Declines
PremiumCompany Announcements
NuCana Posts Wider Q1 2026 Loss as Cash Balance Declines
3M ago
6K
NCNA
NuCana Sets June 8 AGM, Seeks Share Capital Restructuring and Fresh Funding Authorities
PremiumCompany AnnouncementsNuCana Sets June 8 AGM, Seeks Share Capital Restructuring and Fresh Funding Authorities
3M ago
6K
NCNA
NuCana Posts 2025 Results, Highlights NUC-7738 Progress and Cash Runway Into 2029
Premium
Company Announcements
NuCana Posts 2025 Results, Highlights NUC-7738 Progress and Cash Runway Into 2029
5M ago
6K
NCNA
NuCana Names Theresa Bruce Chief Operating Officer to Drive Oncology Pipeline
Premium
Company Announcements
NuCana Names Theresa Bruce Chief Operating Officer to Drive Oncology Pipeline
7M ago
6K
NCNA
NuCana appoints Bruce as COO
PremiumThe Fly
NuCana appoints Bruce as COO
7M ago
NCNA
NuCana Announces Return of CEO Hugh S. Griffith Following Health Leave
PremiumCompany Announcements
NuCana Announces Return of CEO Hugh S. Griffith Following Health Leave
8M ago
6K
NCNA
NuCana Showcases Promising Results for NUC-7738 in Melanoma Treatment
PremiumCompany Announcements
NuCana Showcases Promising Results for NUC-7738 in Melanoma Treatment
8M ago
6K
NCNA
NuCana presents latest clinical data at ESMO 2025 on NUC-7738
PremiumThe Fly
NuCana presents latest clinical data at ESMO 2025 on NUC-7738
8M ago
NCNA
NuCana presents data at ESMO on NUC-7738
PremiumThe FlyNuCana presents data at ESMO on NUC-7738
8M ago
NCNA
NuCana Reports Q3 2025 Financial Results and Board Resignation
Premium
Company Announcements
NuCana Reports Q3 2025 Financial Results and Board Resignation
9M ago
6K
NCNA
NuCana Secures Key Patent for NUC-7738 in China
Premium
Company Announcements
NuCana Secures Key Patent for NUC-7738 in China
10M ago
6K
NCNA
NuCana announces grant of composition-of-matter patent for NUC-7738 in China
PremiumThe Fly
NuCana announces grant of composition-of-matter patent for NUC-7738 in China
10M ago
NCNA
NuCana Presents Promising Data on NUC-7738 at ESMO Congress 2025
PremiumCompany Announcements
NuCana Presents Promising Data on NUC-7738 at ESMO Congress 2025
10M ago
6K
NCNA
NuCana presents data at ESMO 2025 for NUC-7738, PD-1 inhibitors
PremiumThe Fly
NuCana presents data at ESMO 2025 for NUC-7738, PD-1 inhibitors
10M ago
NCNA
NuCana Reports Promising Clinical Data for NUC-3373
PremiumCompany Announcements
NuCana Reports Promising Clinical Data for NUC-3373
10M ago
6K
NCNA
NuCana announces publication of new data for NUC-3373
PremiumThe FlyNuCana announces publication of new data for NUC-3373
10M ago
NCNA
NuCana Achieves Nasdaq Compliance and Secures Cash Runway into 2029
Premium
Company Announcements
NuCana Achieves Nasdaq Compliance and Secures Cash Runway into 2029
12M ago
6K
NCNA
NuCana compliant with all Nasdaq continued listing criteria
Premium
The Fly
NuCana compliant with all Nasdaq continued listing criteria
12M ago
NCNA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >